irinotecan has been researched along with Abdominal Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, M; Ito, M; Kaneda, H; Morioka, I; Oba, D; Yagasaki, H | 1 |
| Assadourian, S; Brooks, M; Cisar, L; Couanet, D; Gentet, JC; Geoerger, B; Geoffray, A; Giammarile, F; Michon, J; Morland, B; Pichon, F; Rubie, H; Schell, M; Stockdale, E; Vassal, G | 1 |
| Anderson, P; Bilton, SD; Chang, EL; Fontanilla, HP; Green, HL; Grosshans, DR; Hayes-Jordan, A; Mahajan, A; McAleer, MF; Pinnix, CC; Subbiah, V; Sulman, EP; Woo, SY | 1 |
| Aubert, G; Bénard, J; Calvet, L; Merlin, JL; Morizet, J; Opolon, P; Santos, A; Schellens, JH; Terrier-Lacombe, MJ; Valent, A; Vassal, G | 1 |
| Anderson, P; Curley, S; Green, HL; Hayes-Jordan, A; Herzog, C; Hunt, K; Lally, KP; Mansfield, P | 1 |
| Bayliff, S; Rosoff, PM | 1 |
1 trial(s) available for irinotecan and Abdominal Neoplasms
| Article | Year |
|---|---|
A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG).
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infant; Injections, Intravenous; Irinotecan; Male; Neoplasm Recurrence, Local; Neuroblastoma; Prospective Studies; Thoracic Neoplasms; Treatment Outcome; Young Adult | 2008 |
5 other study(ies) available for irinotecan and Abdominal Neoplasms
| Article | Year |
|---|---|
Successful treatment of stage 4 rhabdomyosarcoma in a female with Williams-Beuren syndrome.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Irinotecan; Neoplasm Staging; Proton Therapy; Rhabdomyosarcoma; Vincristine; Williams Syndrome | 2020 |
Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
Topics: Abdominal Neoplasms; Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Desmoplastic Small Round Cell Tumor; Erythrocyte Transfusion; Feasibility Studies; Humans; Hyperthermia, Induced; Interferons; Irinotecan; Liver Neoplasms; Male; Pelvic Neoplasms; Peritoneal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Temozolomide; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2012 |
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan.
Topics: Abdominal Neoplasms; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Child, Preschool; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Male; Mice; Mice, Nude; Neuroblastoma; Topoisomerase I Inhibitors; Transplantation, Heterologous | 2004 |
Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Cisplatin; Dacarbazine; Humans; Hyperthermia, Induced; Infusions, Parenteral; Irinotecan; Male; Temozolomide | 2007 |
Successful clinical response to irinotecan in desmoplastic round blue cell tumor.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Small Cell; Desmin; Female; Humans; Irinotecan; Male; Prognosis; Treatment Outcome | 1999 |